NasdaqGS - Nasdaq Real Time Price USD

Diversified Healthcare Trust (DHC)

Compare
3.7900 +0.2200 (+6.16%)
At close: 4:00 PM EDT
3.7900 0.00 (0.00%)
After hours: 4:04 PM EDT
Loading Chart for DHC
DELL
  • Previous Close 3.5700
  • Open 3.5800
  • Bid 3.7900 x 200
  • Ask 3.8300 x 100
  • Day's Range 3.5400 - 3.8250
  • 52 Week Range 1.6900 - 4.2400
  • Volume 676,057
  • Avg. Volume 968,226
  • Market Cap (intraday) 911.779M
  • Beta (5Y Monthly) 2.22
  • PE Ratio (TTM) --
  • EPS (TTM) -1.4800
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield 0.04 (1.12%)
  • Ex-Dividend Date Jul 22, 2024
  • 1y Target Est 4.50

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

www.dhcreit.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DHC

View More

Performance Overview: DHC

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DHC
2.46%
S&P 500
22.49%

1-Year Return

DHC
104.92%
S&P 500
35.00%

3-Year Return

DHC
9.14%
S&P 500
30.66%

5-Year Return

DHC
53.59%
S&P 500
95.03%

Compare To: DHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DHC

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    858.85M

  • Enterprise Value

    3.51B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    0.40

  • Enterprise Value/Revenue

    2.41

  • Enterprise Value/EBITDA

    19.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -24.14%

  • Return on Assets (ttm)

    -0.87%

  • Return on Equity (ttm)

    -15.13%

  • Revenue (ttm)

    1.46B

  • Net Income Avi to Common (ttm)

    -352.46M

  • Diluted EPS (ttm)

    -1.4800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    265.56M

  • Total Debt/Equity (mrq)

    136.88%

  • Levered Free Cash Flow (ttm)

    143.54M

Research Analysis: DHC

View More

Company Insights: DHC

Research Reports: DHC

View More

People Also Watch